Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Opko Health
Biotech
Opko, Entera share cost of 1st oral GLP-1/glucagon agonist study
Opko and Entera have formalized their partnership as the biotechs prepare to take the first oral dual agonist GLP-1/glucagon peptide into the clinic.
James Waldron
Mar 17, 2025 10:10am
Chasing Moderna, Merck pays $50M to join emerging vaccine race
Mar 8, 2023 10:15am
Gunning for China's obesity market, LeaderMed targets US IPO
Sep 1, 2022 6:35pm
